Ohio | 001-11593 | 31-1414921 |
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation or organization) | File Number) | Identification No.) |
14111 Scottslawn Road, Marysville, Ohio | 43041 | |
(Address of principal executive offices) | (Zip Code) |
Exhibit No. | Description |
99.1 | News release issued by The Scotts Miracle-Gro Company on November 7, 2017 |
THE SCOTTS MIRACLE-GRO COMPANY | ||
Dated: November 7, 2017 | By: | /s/ THOMAS RANDAL COLEMAN |
Printed Name: Thomas Randal Coleman | ||
Title: Executive Vice President and Chief Financial Officer |
Exhibit No. | Exhibit Description |
News release issued by The Scotts Miracle-Gro Company on November 7, 2017 |
The Scotts Miracle-Gro Company | NEWS |
• | Operating cash flow of $354 million reflects improvement in earnings and working capital |
• | Hawthorne growth drives Company-wide sales growth of 8% in Q4 and 5% for full year |
• | Q4 GAAP EPS loss of $0.72; Non-GAAP SLS Divestiture Adjusted EPS loss of $0.26 |
• | Full-year GAAP EPS of $3.29; Non-GAAP SLS Divestiture Adjusted EPS of $3.94 |
• | 2018 Guidance: Non-GAAP Adjusted EPS of $4.15 to $4.35 on sales growth of 4 to 6% |
• | Compliance with environmental and other public health regulations could increase the Company’s costs of doing business or limit the Company’s ability to market all of its products; |
• | Increases in the prices of raw materials and fuel costs could adversely affect the Company’s results of operations; |
• | The highly competitive nature of the Company’s markets could adversely affect its ability to maintain or grow revenues; |
• | Because of the concentration of the Company’s sales to a small number of retail customers, the loss of one or more of, or significant reduction in orders from, its top customers could adversely affect the Company’s financial results; |
• | Adverse weather conditions could adversely impact financial results; |
• | The Company’s international operations make the Company susceptible to fluctuations in currency exchange rates and to other costs and risks associated with international regulation; |
• | The Company may not be able to adequately protect its intellectual property and other proprietary rights that are material to the Company’s business; |
• | If Monsanto Company were to terminate the Marketing Agreement for consumer Roundup products, the Company would lose a substantial source of future earnings and overhead expense absorption; |
• | Hagedorn Partnership, L.P. beneficially owns approximately 27% of the Company’s common shares and can significantly influence decisions that require the approval of shareholders; |
• | The Company may pursue acquisitions, dispositions, investments, dividends, share repurchases and/or other corporate transactions that it believes will maximize equity returns of its shareholders but may involve risks. |
Three Months Ended | Twelve Months Ended | |||||||||||||||||||||||
Footnotes | September 30, 2017 | September 30, 2016 | % Change | September 30, 2017 | September 30, 2016 | % Change | ||||||||||||||||||
Net sales | $ | 376.7 | $ | 348.7 | 8 | % | $ | 2,642.1 | $ | 2,506.2 | 5 | % | ||||||||||||
Cost of sales | 288.6 | 256.1 | 1,669.5 | 1,600.0 | ||||||||||||||||||||
Cost of sales—impairment, restructuring and other | — | 0.4 | — | 5.9 | ||||||||||||||||||||
Gross profit | 88.1 | 92.2 | (4 | )% | 972.6 | 900.3 | 8 | % | ||||||||||||||||
% of sales | 23.4 | % | 26.4 | % | 36.8 | % | 35.9 | % | ||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||
Selling, general and administrative | 114.5 | 112.8 | 2 | % | 550.9 | 518.0 | 6 | % | ||||||||||||||||
Impairment, restructuring and other | 3.7 | 2.8 | 4.9 | (51.5 | ) | |||||||||||||||||||
Other income, net | (4.0 | ) | (6.2 | ) | (16.6 | ) | (13.8 | ) | ||||||||||||||||
Income (loss) from operations | (26.1 | ) | (17.2 | ) | (52 | )% | 433.4 | 447.6 | (3 | )% | ||||||||||||||
% of sales | (6.9 | )% | (4.9 | )% | 16.4 | % | 17.9 | % | ||||||||||||||||
Equity in (income) loss of unconsolidated affiliates | (3) | (1.2 | ) | (11.3 | ) | 29.0 | (7.8 | ) | ||||||||||||||||
Costs related to refinancing | — | — | — | 8.8 | ||||||||||||||||||||
Interest expense | 17.7 | 12.8 | 76.1 | 62.9 | ||||||||||||||||||||
Other non-operating expense | 13.4 | — | 13.4 | — | ||||||||||||||||||||
Income (loss) from continuing operations before income taxes | (56.0 | ) | (18.7 | ) | (199 | )% | 314.9 | 383.7 | (18 | )% | ||||||||||||||
Income tax expense (benefit) from continuing operations | (13.7 | ) | (7.4 | ) | 116.6 | 137.6 | ||||||||||||||||||
Income (loss) from continuing operations | (42.3 | ) | (11.3 | ) | (274 | )% | 198.3 | 246.1 | (19 | )% | ||||||||||||||
Income (loss) from discontinued operations, net of tax | (3) (4) | 8.9 | (15.6 | ) | 20.5 | 68.7 | ||||||||||||||||||
Net income (loss) | $ | (33.4 | ) | $ | (26.9 | ) | $ | 218.8 | $ | 314.8 | ||||||||||||||
Net (income) loss attributable to noncontrolling interest | — | 0.3 | (0.5 | ) | 0.5 | |||||||||||||||||||
Net income (loss) attributable to controlling interest | $ | (33.4 | ) | $ | (26.6 | ) | $ | 218.3 | $ | 315.3 | ||||||||||||||
Basic income (loss) per common share: | (1) | |||||||||||||||||||||||
Income (loss) from continuing operations | $ | (0.72 | ) | $ | (0.18 | ) | (300 | )% | $ | 3.33 | $ | 4.04 | (18 | )% | ||||||||||
Income (loss) from discontinued operations | 0.15 | (0.26 | ) | 0.35 | 1.12 | |||||||||||||||||||
Net income (loss) | $ | (0.57 | ) | $ | (0.44 | ) | $ | 3.68 | $ | 5.16 | ||||||||||||||
Diluted income (loss) per common share: | (2) | |||||||||||||||||||||||
Income (loss) from continuing operations | $ | (0.72 | ) | $ | (0.18 | ) | (300 | )% | $ | 3.29 | $ | 3.98 | (17 | )% | ||||||||||
Income (loss) from discontinued operations | 0.15 | (0.26 | ) | 0.34 | 1.11 | |||||||||||||||||||
Net income (loss) | $ | (0.57 | ) | $ | (0.44 | ) | $ | 3.63 | $ | 5.09 | ||||||||||||||
Common shares used in basic income (loss) per share calculation | 58.4 | 60.6 | (4 | )% | 59.4 | 61.1 | (3 | )% | ||||||||||||||||
Common shares and potential common shares used in diluted income (loss) per share calculation | 58.4 | 60.6 | (4 | )% | 60.2 | 62.0 | (3 | )% | ||||||||||||||||
Non-GAAP results: | ||||||||||||||||||||||||
Adjusted net income (loss) attributable to controlling interest from continuing operations | (5) | $ | (14.9 | ) | $ | (12.1 | ) | (23 | )% | $ | 236.9 | $ | 230.7 | 3 | % | |||||||||
Adjusted diluted income (loss) per common share from continuing operations | (2) (5) | $ | (0.26 | ) | $ | (0.20 | ) | (30 | )% | $ | 3.94 | $ | 3.72 | 6 | % | |||||||||
SLS Divestiture adjusted income (loss) | (3) (5) | $ | (14.9 | ) | $ | (11.7 | ) | (27 | )% | $ | 236.9 | $ | 221.7 | 7 | % | |||||||||
SLS Divestiture adjusted income (loss) per common share | (3) (5) | $ | (0.26 | ) | $ | (0.19 | ) | (37 | )% | $ | 3.94 | $ | 3.58 | 10 | % | |||||||||
Adjusted EBITDA | (5) | $ | 5.5 | $ | 5.6 | (2 | )% | $ | 560.5 | $ | 517.4 | 8 | % | |||||||||||
Note: See accompanying footnotes on page 12. |
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||
September 30, 2017 | September 30, 2016 | % Change | September 30, 2017 | September 30, 2016 | % Change | ||||||||||||||||
Net Sales: | |||||||||||||||||||||
U.S. Consumer | $ | 258.1 | $ | 278.9 | (7 | )% | $ | 2,160.5 | $ | 2,204.4 | (2 | )% | |||||||||
Hawthorne | 92.0 | 46.8 | 97 | % | 287.2 | 121.2 | 137 | % | |||||||||||||
Other | 26.6 | 23.0 | 16 | % | 194.4 | 180.6 | 8 | % | |||||||||||||
Consolidated | $ | 376.7 | $ | 348.7 | 8 | % | $ | 2,642.1 | $ | 2,506.2 | 5 | % | |||||||||
Segment Profit (Loss) (Non-GAAP): | |||||||||||||||||||||
U.S. Consumer | $ | (0.3 | ) | $ | 11.2 | (103 | )% | $ | 521.5 | $ | 493.7 | 6 | % | ||||||||
Hawthorne | 9.0 | 5.2 | 73 | % | 35.5 | 11.8 | 201 | % | |||||||||||||
Other | (0.9 | ) | (2.1 | ) | 57 | % | 13.4 | 10.4 | 29 | % | |||||||||||
Total Segment Profit (Non-GAAP) | 7.8 | 14.3 | (45 | )% | 570.4 | 515.9 | 11 | % | |||||||||||||
Corporate | (24.1 | ) | (23.5 | ) | (109.6 | ) | (98.9 | ) | |||||||||||||
Intangible asset amortization | (6.1 | ) | (4.8 | ) | (22.5 | ) | (14.9 | ) | |||||||||||||
Impairment, restructuring and other | (3.7 | ) | 2.1 | (4.9 | ) | 33.8 | |||||||||||||||
Equity in income (loss) of unconsolidated affiliates(a) | 1.2 | 6.0 | (29.0 | ) | 19.5 | ||||||||||||||||
Costs related to refinancing | — | — | — | (8.8 | ) | ||||||||||||||||
Interest expense | (17.7 | ) | (12.8 | ) | (76.1 | ) | (62.9 | ) | |||||||||||||
Other non-operating expense(b) | (13.4 | ) | — | (13.4 | ) | — | |||||||||||||||
Income (loss) from continuing operations before income taxes (GAAP) | $ | (56.0 | ) | $ | (18.7 | ) | (199 | )% | $ | 314.9 | $ | 383.7 | (18 | )% |
(a) | Included within equity in income (loss) of unconsolidated affiliates for the three and twelve months ended September 30, 2017 are charges of $8.4 million and $25.2 million, respectively, which represent the Company’s share of restructuring and other charges incurred by the TruGreen Joint Venture, including a charge of $7.2 million related to costs associated with TruGreen’s August 2017 refinancing. For the three and twelve months ended September 30, 2016, the Company’s share of restructuring and other charges incurred by the TruGreen Joint Venture of $(5.3) million and $11.7 million, respectively, were included within impairment, restructuring and other above. |
(b) | Included within other non-operating expense for the three and twelve months ended September 30, 2017 is a charge of $13.4 million, driven by the October 2017 acquisition of the remaining noncontrolling interest in Gavita, to write-up the fair value of the loan to the noncontrolling ownership group of Gavita to the agreed upon buyout value. |
Footnotes | September 30, 2017 | September 30, 2016 | ||||||||
ASSETS | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | $ | 120.5 | $ | 28.6 | ||||||
Accounts receivable, net | 286.6 | 301.7 | ||||||||
Inventories | 407.5 | 394.7 | ||||||||
Assets held for sale | (4 | ) | — | 256.2 | ||||||
Prepaid and other current assets | (7 | ) | 67.1 | 51.7 | ||||||
Total current assets | 881.7 | 1,032.9 | ||||||||
Investment in unconsolidated affiliates | 31.1 | 101.0 | ||||||||
Property, plant and equipment, net | 467.7 | 444.9 | ||||||||
Goodwill | 441.6 | 371.9 | ||||||||
Intangible assets, net | 748.9 | 690.0 | ||||||||
Other assets | (6 | ) | 176.0 | 115.1 | ||||||
Total assets | $ | 2,747.0 | $ | 2,755.8 | ||||||
LIABILITIES AND EQUITY | ||||||||||
Current liabilities: | ||||||||||
Current portion of debt | $ | 143.1 | $ | 185.0 | ||||||
Accounts payable | 153.1 | 131.2 | ||||||||
Liabilities held for sale | (4 | ) | — | 213.0 | ||||||
Other current liabilities | 248.3 | 177.9 | ||||||||
Total current liabilities | 544.5 | 707.1 | ||||||||
Long-term debt | (6 | ) | 1,258.0 | 1,030.9 | ||||||
Distributions in excess of investment in unconsolidated affiliate | 21.9 | — | ||||||||
Other liabilities | (7 | ) | 260.9 | 283.5 | ||||||
Total liabilities | 2,085.3 | 2,021.5 | ||||||||
Equity | 661.7 | 734.3 | ||||||||
Total liabilities and equity | $ | 2,747.0 | $ | 2,755.8 |
Year Ended September 30, | |||||||
2017 | 2016 | ||||||
OPERATING ACTIVITIES | |||||||
Net income | $ | 218.8 | $ | 314.8 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Impairment, restructuring and other | 1.2 | 0.2 | |||||
Costs related to refinancing | — | 2.2 | |||||
Share-based compensation expense | 25.2 | 15.6 | |||||
Depreciation | 55.1 | 53.8 | |||||
Amortization | 25.0 | 19.7 | |||||
Deferred taxes | (17.4 | ) | 83.6 | ||||
Gain on long-lived assets | (3.3 | ) | (0.8 | ) | |||
Gain on sale / contribution of business | (31.7 | ) | (131.2 | ) | |||
Equity in (income) loss and distributions from unconsolidated affiliates | 32.6 | (0.3 | ) | ||||
Changes in assets and liabilities, net of acquired businesses: | |||||||
Accounts receivable | 48.6 | (29.8 | ) | ||||
Inventories | 3.6 | (29.4 | ) | ||||
Prepaid and other assets | (12.2 | ) | (9.3 | ) | |||
Accounts payable | 9.0 | (45.3 | ) | ||||
Other current liabilities | 26.9 | 22.9 | |||||
Restructuring | (8.7 | ) | (7.3 | ) | |||
Other non-current items | (19.6 | ) | (18.4 | ) | |||
Other, net | 0.9 | (3.6 | ) | ||||
Net cash provided by operating activities | 354.0 | 237.4 | |||||
INVESTING ACTIVITIES | |||||||
Proceeds from sale of long-lived assets | 5.7 | 2.4 | |||||
Proceeds from sale of business, net of cash disposed of | 180.3 | — | |||||
Investments in property, plant and equipment | (69.6 | ) | (58.3 | ) | |||
Investments in loans receivable | (29.7 | ) | (90.0 | ) | |||
Cash contributed to TruGreen Joint Venture | — | (24.2 | ) | ||||
Net distributions from unconsolidated affiliates | 57.4 | 194.1 | |||||
Investments in acquired businesses, net of cash acquired | (121.7 | ) | (158.4 | ) | |||
Net cash (used in) provided by investing activities | 22.4 | (134.4 | ) | ||||
FINANCING ACTIVITIES | |||||||
Borrowings under revolving and bank lines of credit and term loans | 1,449.3 | 2,069.1 | |||||
Repayments under revolving and bank lines of credit and term loans | (1,618.3 | ) | (2,150.4 | ) | |||
Proceeds from issuance of 5.250% Senior Notes | 250.0 | — | |||||
Proceeds from issuance of 6.000% Senior Notes | — | 400.0 | |||||
Repayment of 6.625% Senior Notes | — | (200.0 | ) | ||||
Financing and issuance fees | (4.4 | ) | (11.2 | ) | |||
Dividends paid | (120.3 | ) | (116.6 | ) | |||
Distribution paid by AeroGrow to noncontrolling interest | (8.1 | ) | — | ||||
Purchase of Common Shares | (246.0 | ) | (130.8 | ) | |||
Payments on sellers notes | (28.7 | ) | (2.8 | ) | |||
Excess tax benefits from share-based payment arrangements | 7.9 | 5.8 | |||||
Cash received from exercise of stock options | 11.0 | 14.7 | |||||
Net cash used in financing activities | (307.6 | ) | (122.2 | ) | |||
Effect of exchange rate changes on cash | 1.6 | (2.1 | ) | ||||
Net increase (decrease) in cash and cash equivalents | 70.4 | (21.3 | ) | ||||
Cash and cash equivalents at beginning of year excluding cash classified within assets held for sale | 28.6 | 50.8 | |||||
Cash and cash equivalents at beginning of year classified within assets held for sale | 21.5 | 20.6 | |||||
Cash and cash equivalents at beginning of year | 50.1 | 71.4 | |||||
Cash and cash equivalents at end of year | $ | 120.5 | $ | 50.1 |
Three Months Ended September 30, 2017 | Three Months Ended September 30, 2016 | ||||||||||||||||||||||||||
Footnotes | As Reported (GAAP) | Discontinued Operations | Impairment, Restructuring and Other | Adjusted (Non-GAAP) | As Reported (GAAP) | Discontinued Operations | Impairment, Restructuring and Other | Adjusted (Non-GAAP) | |||||||||||||||||||
Gross profit | $ | 88.1 | $ | — | $ | — | $ | 88.1 | $ | 92.2 | $ | — | $ | (0.4 | ) | $ | 92.6 | ||||||||||
Gross profit as a % of sales | 23.4 | % | 23.4 | % | 26.4 | % | 26.6 | % | |||||||||||||||||||
Loss from operations | (26.1 | ) | — | (3.7 | ) | (22.4 | ) | (17.2 | ) | — | (3.2 | ) | (14.0 | ) | |||||||||||||
Loss from operations as a % of sales | (6.9 | )% | (5.9 | )% | (4.9 | )% | (4.0 | )% | |||||||||||||||||||
Equity income loss of unconsolidated affiliates | (3) | (1.2 | ) | — | 8.4 | (9.6 | ) | (11.3 | ) | — | (5.3 | ) | (6.0 | ) | |||||||||||||
Other non-operating expense | 13.4 | — | 13.4 | — | — | — | — | — | |||||||||||||||||||
Loss from continuing operations before income taxes | (56.0 | ) | — | (25.5 | ) | (30.5 | ) | (18.7 | ) | — | 2.1 | (20.8 | ) | ||||||||||||||
Income tax benefit from continuing operations | (13.7 | ) | — | 1.9 | (15.6 | ) | (7.4 | ) | — | 1.0 | (8.4 | ) | |||||||||||||||
Loss from continuing operations | (42.3 | ) | — | (27.4 | ) | (14.9 | ) | (11.3 | ) | — | 1.1 | (12.4 | ) | ||||||||||||||
Net loss attributable to controlling interest | (33.4 | ) | 8.9 | (27.4 | ) | (14.9 | ) | (26.6 | ) | (15.6 | ) | 1.1 | (12.1 | ) | |||||||||||||
Diluted loss per common share from continuing operations | (0.72 | ) | — | (0.47 | ) | (0.26 | ) | (0.18 | ) | — | 0.02 | (0.20 | ) |
Calculation of Adjusted EBITDA (5): | Three Months Ended September 30, 2017 | Three Months Ended September 30, 2016 | ||||||
Net loss (GAAP) | $ | (33.4 | ) | $ | (26.9 | ) | ||
Income tax benefit from continuing operations | (13.7 | ) | (7.4 | ) | ||||
Income tax expense (benefit) from discontinued operations | 8.0 | (8.2 | ) | |||||
Gain on sale / contribution of business | (32.0 | ) | 11.4 | |||||
Interest expense | 17.7 | 13.3 | ||||||
Depreciation | 13.7 | 13.6 | ||||||
Amortization | 6.6 | 5.6 | ||||||
Impairment, restructuring and other from continuing operations | 25.5 | (2.1 | ) | |||||
Impairment, restructuring and other from discontinued operations | 7.5 | 3.5 | ||||||
Expense on certain leases | 0.9 | 0.9 | ||||||
Share-based compensation expense | 4.7 | 1.9 | ||||||
Adjusted EBITDA (Non-GAAP) | $ | 5.5 | $ | 5.6 | ||||
Note: See accompanying footnotes on page 12. | ||||||||
The sum of the components may not equal due to rounding. |
Twelve Months Ended September 30, 2017 | Twelve Months Ended September 30, 2016 | |||||||||||||||||||||||||||||
Footnotes | As Reported (GAAP) | Discontinued Operations | Impairment, Restructuring and Other | Adjusted (Non-GAAP) | As Reported (GAAP) | Discontinued Operations | Impairment, Restructuring and Other | Costs Related to Refinancing | Adjusted (Non-GAAP) | |||||||||||||||||||||
Gross profit | $ | 972.6 | $ | — | $ | — | $ | 972.6 | $ | 900.3 | $ | — | $ | (6.0 | ) | $ | — | $ | 906.3 | |||||||||||
Gross profit as a % of sales | 36.8 | % | 36.8 | % | 35.9 | % | 36.2 | % | ||||||||||||||||||||||
Income from operations | 433.4 | — | (4.9 | ) | 438.3 | 447.6 | — | 45.5 | — | 402.1 | ||||||||||||||||||||
Income from operations as a % of sales | 16.4 | % | 16.6 | % | 17.9 | % | 16.0 | % | ||||||||||||||||||||||
Equity in (income) loss of unconsolidated affiliates | (3) | 29.0 | — | 25.2 | 3.8 | (7.8 | ) | — | 11.7 | — | (19.5 | ) | ||||||||||||||||||
Other non-operating expense | 13.4 | — | 13.4 | — | — | — | — | — | — | |||||||||||||||||||||
Income from continuing operations before income taxes | 314.9 | — | (43.5 | ) | 358.4 | 383.7 | — | 33.8 | (8.8 | ) | 358.7 | |||||||||||||||||||
Income tax expense from continuing operations | 116.6 | — | (4.4 | ) | 121.0 | 137.6 | — | 12.2 | (3.1 | ) | 128.5 | |||||||||||||||||||
Income from continuing operations | 198.3 | — | (39.1 | ) | 237.4 | 246.1 | — | 21.6 | (5.7 | ) | 230.2 | |||||||||||||||||||
Net income attributable to controlling interest | 218.3 | 20.5 | (39.1 | ) | 236.9 | 315.3 | 68.7 | 21.6 | (5.7 | ) | 230.7 | |||||||||||||||||||
Diluted income per common share from continuing operations | 3.29 | — | (0.65 | ) | 3.94 | 3.98 | — | 0.35 | (0.09 | ) | 3.72 |
Calculation of Adjusted EBITDA (5): | Twelve Months Ended September 30, 2017 | Twelve Months Ended September 30, 2016 | ||||||
Net income (GAAP) | $ | 218.8 | $ | 314.8 | ||||
Income tax expense from continuing operations | 116.6 | 137.6 | ||||||
Income tax expense from discontinued operations | 11.9 | 43.2 | ||||||
Gain on sale / contribution of business | (31.7 | ) | (131.2 | ) | ||||
Costs related to refinancing | — | 8.8 | ||||||
Interest expense | 76.6 | 65.6 | ||||||
Depreciation | 55.1 | 53.8 | ||||||
Amortization | 25.0 | 19.7 | ||||||
Impairment, restructuring and other from continuing operations | 43.5 | (33.8 | ) | |||||
Impairment, restructuring and other from discontinued operations | 15.9 | 19.7 | ||||||
Expense on certain leases | 3.6 | 3.6 | ||||||
Share-based compensation expense | 25.2 | 15.6 | ||||||
Adjusted EBITDA (Non-GAAP) | $ | 560.5 | $ | 517.4 |
Year Ended September 30, | ||||||||
2017 | 2016 | |||||||
Calculation of free cash flow (5): | ||||||||
Net cash provided by operating activities (GAAP) | $ | 354.0 | $ | 237.4 | ||||
Investments in property, plant and equipment | (69.6 | ) | (58.3 | ) | ||||
Free cash flow (Non-GAAP) | $ | 284.4 | $ | 179.1 | ||||
Calculation of free cash flow productivity (5): | ||||||||
Free cash flow (Non-GAAP) | $ | 284.4 | $ | 179.1 | ||||
Net income (GAAP) | 218.8 | 314.8 | ||||||
Free cash flow productivity (Non-GAAP) | 130.0 | % | 56.9 | % | ||||
Note: See accompanying footnotes on page 12. | ||||||||
The sum of the components may not equal due to rounding. |
Three Months Ended | Twelve Months Ended | ||||||||||||||
September 30, 2017 | September 30, 2016 | September 30, 2017 | September 30, 2016 | ||||||||||||
Calculation of SLS Divestiture adjusted income (loss): | |||||||||||||||
Reported income (loss) from continuing operations (GAAP) | $ | (42.3 | ) | $ | (11.3 | ) | $ | 198.3 | $ | 246.1 | |||||
Net (income) loss attributable to noncontrolling interest | — | 0.3 | (0.5 | ) | 0.5 | ||||||||||
Net income (loss) attributable to controlling interest from continuing operations | (42.3 | ) | (11.0 | ) | 197.8 | 246.6 | |||||||||
Impairment, restructuring and other | 25.5 | (2.1 | ) | 43.5 | (33.8 | ) | |||||||||
Costs related to refinancing | — | — | — | 8.8 | |||||||||||
Adjustment to income tax (expense) benefit from continuing operations | 1.9 | 1.0 | (4.4 | ) | 9.1 | ||||||||||
Adjusted net income (loss) attributable to controlling interest from continuing operations (Non-GAAP) | (14.9 | ) | (12.1 | ) | 236.9 | 230.7 | |||||||||
Income (loss) from discontinued operations from SLS Business | (0.7 | ) | (11.4 | ) | (1.8 | ) | 102.9 | ||||||||
Gain on contribution of SLS Business | — | — | — | (131.2 | ) | ||||||||||
Adjustment to gain on contribution of SLS Business | 0.7 | 11.4 | 1.0 | — | |||||||||||
Impairment, restructuring and other from SLS Business in discontinued operations | — | — | 0.8 | 13.6 | |||||||||||
Adjustment to income tax benefit from discontinued operations | — | 0.4 | — | 5.7 | |||||||||||
Adjusted income (loss) from SLS Business in discontinued operations, net of tax | — | 0.4 | — | (9.0 | ) | ||||||||||
SLS Divestiture adjusted income (loss) (Non-GAAP) | $ | (14.9 | ) | $ | (11.7 | ) | $ | 236.9 | $ | 221.7 | |||||
Reported diluted income (loss) per common share from continuing operations (GAAP) | $ | (0.72 | ) | $ | (0.18 | ) | $ | 3.29 | $ | 3.98 | |||||
Impairment, restructuring and other | 0.44 | (0.03 | ) | 0.72 | (0.55 | ) | |||||||||
Costs related to refinancing | — | — | — | 0.14 | |||||||||||
Adjustment to income tax (expense) benefit from continuing operations | 0.03 | 0.02 | (0.07 | ) | 0.15 | ||||||||||
Adjusted diluted income (loss) per common share from continuing operations (Non-GAAP) | (0.26 | ) | (0.20 | ) | 3.94 | 3.72 | |||||||||
Income (loss) from discontinued operations from SLS Business | (0.01 | ) | (0.19 | ) | (0.03 | ) | 1.66 | ||||||||
Gain on contribution of SLS Business | — | — | — | (2.12 | ) | ||||||||||
Adjustment to gain on contribution of SLS Business | 0.01 | 0.19 | 0.02 | — | |||||||||||
Impairment, restructuring and other from SLS Business in discontinued operations | — | — | 0.01 | 0.22 | |||||||||||
Adjustment to income tax benefit from discontinued operations | — | 0.01 | — | 0.09 | |||||||||||
Adjusted diluted income (loss) from SLS Business in discontinued operations, net of tax | — | 0.01 | — | (0.15 | ) | ||||||||||
SLS Divestiture adjusted income (loss) per common share (Non-GAAP) | $ | (0.26 | ) | $ | (0.19 | ) | $ | 3.94 | $ | 3.58 | |||||
Common shares and potential common shares used in SLS Divestiture adjusted income (loss) per share calculation | 58.4 | 60.6 | 60.2 | 62.0 | |||||||||||
Note: See accompanying footnotes on page 12. | |||||||||||||||
The sum of the components may not equal due to rounding. |
(1) | Basic income (loss) per common share amounts are calculated by dividing income (loss) from continuing operations, income (loss) from discontinued operations and net income (loss) attributable to controlling interest by the weighted average number of common shares outstanding during the period. |
(2) | Diluted income (loss) per common share amounts are calculated by dividing income (loss) from continuing operations, income (loss) from discontinued operations and net income (loss) attributable to controlling interest by the weighted average number of common shares, plus all potential dilutive securities (common stock options, performance shares, performance units, restricted stock and restricted stock units) outstanding during the period. |
(3) | On April 13, 2016, pursuant to the terms of the Contribution and Distribution Agreement, by and among the Company and TruGreen Holding Corporation (“TruGreen Holdings”), the Company completed the contribution of the Scotts LawnService® business (the “SLS Business”) to a newly formed subsidiary of TruGreen Holdings (the “TruGreen Joint Venture”) in exchange for a minority equity interest of 30% in the TruGreen Joint Venture. As a result, effective in its second quarter of fiscal 2016, the Company classified its results of operations for all periods presented to reflect the SLS Business as a discontinued operation and classified the assets and liabilities of the SLS Business as held for sale. The Company’s 30% interest in the TruGreen Joint Venture has been accounted for using the equity method of accounting, with the Company's proportionate share of the TruGreen Joint Venture earnings reflected in the consolidated statements of operations. |
(4) | On April 29, 2017, The Scotts Miracle-Gro Company (the “Company”) received a binding and irrevocable conditional offer (the “Offer”) from Exponent Private Equity LLP (“Exponent”) to purchase its consumer lawn and garden business in certain international jurisdictions (the “International Business”). On July 5, 2017, the Company accepted the Offer and entered into the Share and Business Sale Agreement (the “Agreement”) contemplated by the Offer. The transaction closed on August 31, 2017. Pursuant to the Agreement, Scotts-Sierra Investments LLC, an indirect wholly-owned subsidiary of the Company (“Sierra”) and certain of its direct and indirect subsidiaries, entered into separate stock or asset sale transactions with respect to the consumer lawn and garden businesses located in Australia, Austria, Benelux, Czech Republic, France, Germany, Poland and the United Kingdom. As a result, effective in its fourth quarter of fiscal 2017, the Company classified its results of operations for all periods presented to reflect the International Business as a discontinued operation and classified the assets and liabilities of the International Business as held for sale. |
(5) | Reconciliation of Non-GAAP Measures |
• | Impairments, which are excluded because they do not occur in or reflect the ordinary course of the Company’s ongoing business operations and their exclusion results in a metric that provides supplemental information about the sustainability of operating performance. |
• | Restructuring and employee severance costs, which include charges for discrete projects or transactions that fundamentally change the Company’s operations and are excluded because they are not part of the ongoing operations of its underlying business, which includes normal levels of reinvestment in the business. |
• | Costs related to refinancing, which are excluded because they do not typically occur in the normal course of business and may obscure analysis of trends and financial performance. Additionally, the amount and frequency of these types of charges is not consistent and is significantly impacted by the timing and size of debt financing transactions. |
• | Charges or credits incurred by the TruGreen Joint Venture that are apart from and not indicative of the results of its ongoing operations, including transaction related costs, refinancing costs, restructurings and other discrete projects or transactions including a non-cash purchase accounting fair value write down adjustment related to deferred revenue and advertising (“TruGreen Joint Venture non-GAAP adjustments”). |
• | Discontinued operations and other unusual items, which include costs or gains related to discrete projects or transactions and are excluded because they are not comparable from one period to the next and are not part of the ongoing operations of the Company’s underlying business. |
• | The Company incurred restructuring costs related to termination benefits and facility closure costs of $7.1 million and $8.3 million for the three and twelve months ended September 30, 2017, respectively, related to Project Focus activity within the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. |
• | The Company recognized a recovery of $4.4 million related to the reduction of a contingent consideration liability associated with a historical acquisition and recorded a $1.0 million impairment charge on the write-off of a trademark asset due to recent performance and future growth expectations. These items were recorded within the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. |
• | In connection with the October 2017 acquisition of the remaining noncontrolling interest in Gavita, the Company incurred a charge of $13.4 million, which is not tax-deductible, to write-up the fair value of the loan to the noncontrolling ownership group of Gavita to the agreed upon buyout value within the “Other non-operating expense” line in the Condensed Consolidated Statements of Operations. |
• | The Company incurred TruGreen Joint Venture non-GAAP adjustments of $8.4 million and $25.2 million for the three and twelve months ended September 30, 2017, respectively, within the “Equity in (income) loss of unconsolidated affiliates” line in the Condensed Consolidated Statements of Operations. For the three and twelve months ended September 30, 2017, this included a charge of $7.2 million related to costs associated with TruGreen’s August 2017 refinancing. The remaining adjustments include nonrecurring integration and separation costs, transaction costs and a non-cash purchase accounting fair value write down adjustment related to deferred revenue and advertising. |
• | In connection with the sale of the International Business, the Company recognized additional tax expense of $7.2 million associated with valuation allowances established in connection with historical foreign tax credits as the Company does not expect to utilize these prior to their expiration. |
• | For the three and twelve months ended September 30, 2016, the Company incurred ($0.5) million and $6.4 million, respectively, in costs related to consumer complaints and claims related to the reformulated Bonus® S fertilizer product sold in the southeastern United States during fiscal 2015 within the “Impairment, restructuring and other” and the “Cost of sales—impairment, restructuring and other” lines in the Condensed Consolidated Statements of Operations. Additionally, the Company recorded offsetting insurance reimbursement recoveries of zero and $55.9 million for the three and twelve months ended September 30, 2016, respectively, within the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. |
• | The Company incurred restructuring costs related to termination benefits and transaction activity of $3.7 million and $4.0 million for the three and twelve months ended September 30, 2016, respectively, related to Project Focus activity within the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. |
• | The Company incurred TruGreen Joint Venture non-GAAP adjustments of $(5.3) million and $11.7 million for the three and twelve months ended September 30, 2016, respectively, within the “Equity in (income) loss of unconsolidated affiliates” line in the Condensed Consolidated Statements of Operations. |
(6) | In April 2015, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update that requires debt issuance costs related to a recognized debt liability to be presented in the balance sheet as a direct deduction from the corresponding debt liability rather than as an asset; however debt issuance costs relating to revolving credit facilities will remain in other assets. The Company adopted this guidance on a retrospective basis effective October 1, 2016. As a result, debt issuance costs totaling $6.0 million have been presented as a component of the carrying amount of long-term debt in the Condensed Consolidated Balance Sheets as of September 30, 2016. This amount was previously reported within other assets. |
(7) | In November 2015, the FASB issued an accounting standard update to simplify the presentation of deferred income taxes by requiring that deferred income tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The Company adopted this guidance on a retrospective basis during the fourth quarter of fiscal 2017. As a result, deferred tax assets totaling $43.7 million have been presented net within other liabilities in the Condensed Consolidated Balance Sheets as of September 30, 2016. This amount was previously reported within prepaids and other current assets. |